triggered peptides tirzepatide Buy Canada: 99%+ Pure GIP/GLP-1 Research Peptide Tirzepatide

Tirzepatide (Mounjaro, Zepbound) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)

20 to 30 units per day per peptide on a 1 ml insulin syringe, equal to 0.40 to 0.60 mg per injection

GLP-1s are an effective tool that can be part of an effective obesity treatment plan

What you do between injections determines whether you achieve the 15-22% body weight reduction seen in clinical trials or fall short of your goals

Compounded drugs are prepared by state-licensed compounding pharmacies that meet federal and state requirements, including quality standards

Losing weight can lower the stress on the heart and joints, reduce inflammation in the body, and improve overall quality of life